Dance Aerobics for Parkinson's Disease
(PDAE in PD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how partnered dance aerobic exercise (PDAE), inspired by Argentine tango, can benefit people with Parkinson's disease (PD) by reducing "OFF-time" (periods when medications aren't effective) and enhancing cognitive abilities. Researchers compare PDAE to regular walking aerobic exercise (WAE) to determine which is more effective. The goal is to discover if these physical activities can protect brain cells and improve mobility and cognitive function in people with PD. Individuals who have PD, experience OFF-time, and find symptom relief from medication might be suitable for this trial. Participants should feel comfortable with exercise and be willing to be randomly assigned to either the dance or walking group. As an unphased trial, this study provides a unique opportunity to explore innovative exercise methods that could enhance the quality of life for those with PD.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you must show clear symptomatic benefit from antiparkinsonian medications to participate, and you cannot be taking moderate to high doses of beta-blockers with a resting heart rate below 60 beats/min.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop your current medications. However, you must show clear benefits from your current Parkinson's medications to participate.
What prior data suggests that this partnered dance aerobic exercise is safe for people with Parkinson's disease?
Research shows that partnered dance aerobic exercise (PDAE) is generally well-tolerated by people with Parkinson's disease. Studies have found that PDAE can reduce "OFF-time," when medications are less effective, and improve movement and cognitive skills, such as spatial awareness.
Walking aerobic exercise (WAE), used for comparison, provides a similar amount of exercise and interaction. Both exercises occur in a safe and socially engaging environment, ensuring participant safety.
Overall, aerobic exercises like PDAE and WAE are considered safe and beneficial for people with Parkinson's, with no major negative effects reported in existing studies. This suggests they are viable options for managing Parkinson's symptoms.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores partnered dance aerobics as a novel way to help people with Parkinson's disease. Unlike standard treatments that often focus on medication or physical therapy, this method uses adapted Argentine tango to improve motor skills through dance. Participants learn to interpret motor goals through touch and music, which could enhance muscle memory and movement coordination. This socially engaging and interactive approach is expected to offer not just physical benefits but also boost mood and cognitive function, making it a distinctive alternative to typical exercise routines.
What evidence suggests that this trial's treatments could be effective for Parkinson's disease?
Research has shown that Partnered Dance Aerobic Exercise (PDAE), a treatment in this trial, can help people with Parkinson's disease by reducing OFF-time, when medications aren't effective. One study found that PDAE decreases OFF-time, as measured by a special scale used by movement disorder experts. This exercise improves balance, mobility, and cognitive skills. Studies have demonstrated that PDAE increases activity in brain areas involved in decision-making and thought processes. People with Parkinson's disease have experienced better spatial cognition, meaning they can better understand and remember their surroundings. This suggests PDAE might also help protect brain cells, although this has not been confirmed yet.23567
Who Is on the Research Team?
Madeleine E. Hackney, PhD
Principal Investigator
Atlanta VA Medical and Rehab Center, Decatur, GA
Are You a Good Fit for This Trial?
This trial is for people over 40 with Parkinson's Disease who can walk at least 10 feet, have mild cognitive impairment or better, and experience 'OFF-time' when their medication isn't effective. They must see benefits from Parkinson's medications and speak English well. Excluded are those with major depression, brain injuries, severe hearing loss, past PDAE/WAE class attendance, alcohol abuse, plans to move away soon, MRI contraindications like claustrophobia or metal implants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in either Partnered Dance Aerobic Exercise (PDAE) or Walking Aerobic Exercise (WAE) for 16 months. The first 3 months involve twice-weekly sessions, followed by once-weekly sessions for the remaining 13 months.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of OFF-time, cognitive tests, and brain imaging.
What Are the Treatments Tested in This Trial?
Interventions
- Partnered Dance Aerobic Exercise
- WAE
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor